GlaxoSmithKline's US headquarters at the Philadelphia Navy Yard (Robert K. Chin - Storefronts/Alamy)

Glax­o­SmithK­line aban­don­ing icon­ic US HQ space in a shift in­spired by the new nor­mal

Glax­o­SmithK­line is rad­i­cal­ly down­siz­ing — and the move has noth­ing to do with their head count.

Spurred by the pan­dem­ic-in­spired re­duc­tion in the need for of­fice space, the phar­ma gi­ant is giv­ing up its icon­ic fa­cil­i­ties in Philadel­phia and Re­search Tri­an­gle Park, and re­plac­ing the space with new digs that re­quire on­ly a frac­tion of what they once used.

Start­ing ear­ly next year, Glax­o­SmithK­line will be shrink­ing its of­fice space in Philly by 75% as the phar­ma leaves their be­spoke build­ing in the Navy Yard — mov­ing to the FMC Tow­er in Philly’s Uni­ver­si­ty City dis­trict. The com­pa­ny is al­so mov­ing its of­fices from RTP to down­town Durham, NC by June, the com­pa­ny said — a down­size of close to 90%.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.